Abstract | BACKGROUND:
Thromboinflammation involving platelet adhesion to endothelial surface-associated von Willebrand factor (VWF) has been implicated in the accelerated progression of non-culprit plaques after MI. The aim of this study was to use arterial endothelial molecular imaging to mechanistically evaluate endothelial-associated VWF as a therapeutic target for reducing remote plaque activation after myocardial infarction (MI). METHODS: Hyperlipidemic mice deficient for the low-density lipoprotein receptor and Apobec-1 underwent closed-chest MI and were treated chronically with either: (i) recombinant ADAMTS13 which is responsible for proteolytic removal of VWF from the endothelial surface, (ii) N-acetylcysteine (NAC) which removes VWF by disulfide bond reduction, (iii) function-blocking anti- factor XI (FXI) antibody, or (iv) no therapy. Non-ischemic controls were also studied. At day 3 and 21, ultrasound molecular imaging was performed with probes targeted to endothelial-associated VWF A1-domain, platelet GPIbα, P-selectin and vascular cell adhesion molecule-1 (VCAM-1) at lesion-prone sites of the aorta. Histology was performed at day 21. RESULTS: Aortic signal for P-selectin, VCAM-1, VWF, and platelet-GPIbα were all increased several-fold (p < 0.01) in post-MI mice versus sham-treated animals at day 3 and 21. Treatment with NAC and ADAMTS13 significantly attenuated the post-MI increase for all four molecular targets by > 50% (p < 0.05 vs. non-treated at day 3 and 21). On aortic root histology, mice undergoing MI versus controls had 2-4 fold greater plaque size and macrophage content (p < 0.05), approximately 20-fold greater platelet adhesion (p < 0.05), and increased staining for markers of platelet transforming growth factor-β1 signaling. Accelerated plaque growth and inflammatory activation was almost entirely prevented by ADAMTS13 and NAC. Inhibition of FXI had no significant effect on molecular imaging signal or plaque morphology. CONCLUSIONS: Plaque inflammatory activation in remote arteries after MI is strongly influenced by VWF-mediated platelet adhesion to the endothelium. These findings support investigation into new secondary preventive therapies for reducing non-culprit artery events after MI.
|
Authors | Koya Ozawa, William Packwood, Matthew A Muller, Yue Qi, Aris Xie, Oleg Varlamov, Owen J McCarty, Dominic Chung, José A López, Jonathan R Lindner |
Journal | Journal of translational medicine
(J Transl Med)
Vol. 22
Issue 1
Pg. 412
(May 01 2024)
ISSN: 1479-5876 [Electronic] England |
PMID | 38693516
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
|
Copyright | © 2024. The Author(s). |
Chemical References |
- von Willebrand Factor
- ADAMTS13 Protein
- Vascular Cell Adhesion Molecule-1
- P-Selectin
- Acetylcysteine
|
Topics |
- Animals
- von Willebrand Factor
(metabolism)
- Myocardial Infarction
(pathology, complications)
- ADAMTS13 Protein
(metabolism)
- Vascular Cell Adhesion Molecule-1
(metabolism)
- Mice
- Plaque, Atherosclerotic
(pathology)
- P-Selectin
(metabolism)
- Endothelial Cells
(metabolism, drug effects)
- Male
- Molecular Imaging
- Aorta
(pathology, drug effects)
- Acetylcysteine
(pharmacology, therapeutic use)
- Mice, Inbred C57BL
|